Ramazan Gözüküçük

Ramazan Gözüküçük

Auto-generated profile, based on publicly available information

Ramazan Gözüküçük

Department of Infectious Disease and Microbiology, Hisar Intercontinental Hospital, İstanbul, Türkiye

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2013 in ISRN Urology
Verified
Journal Article
Open access
PDF file
BCBasri Cakiroglu
Basri Cakiroglu
OSOrhun Sinanoglu
Orhun Sinanoglu
RGRamazan Gozukucuk
Ramazan Gozukucuk
Background. To compare preoperative and postoperative sperm parameters such as sperm count, motility, and morphology in patients with normal sperm concentration with teratozoospermia and asthenozoospermia. Materials and Methods. Hundred and six patients with varicocele associated with male infertility over a 5-year period were included into the study. Pre- and postvaricocelectomy seminal fluid parameters evaluation according to the World Health Organization (WHO) criteria was performed at 4–6-month intervals. Results. One hundred and six patients met the criteria. The mean age of patients was 24.53 ± 8.13. The mean duration of infertility was 3.6 years (range: 1.5–6.3). Only the sperm motility of patients with normospermia showed a significant improvement postoperatively. Conclusions. No significant improvement in sperm morphology may be obtained in patients with clinical varicocele and preoperative normospermia.

8 July 2023 in Pakistan Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
RGRamazan Gozukucuk
Ramazan Gozukucuk
HKHasan Huseyin Kilic
Hasan Huseyin Kilic
Objective: To examine the use of anti-cytokine treatment in critical COVID-19 patients and their association with the frequency of CMV cases, viral load level, and mortality in these patients. Methods: This is a retrospective study. A total of 170 critical and/or intensive care patients with COVID-19 admitted to Hisar Hospital Intercontinental from March 15, 2020, to December 31, 2021 were divided into the use of anti-cytokine treatment group and the no anti-cytokine treatment group. Furthermore, the relationship between CMV reactivation, mortality and anti-cytokine treatment in patients was also examined. Results: A total of 170 critical COVID-19 patients were included in the study, three of them were excluded. One hundred sixty seven were included in the study of which 38 (22.7%) were found to be CMV DNA positive. As an anti-cytokine treatment, it was observed that tocilizumab was used in 53 patients, anakinra was used in 27 patients, and no anti-cytokine treatment was used in 77 patients. CMV positivity in patients treated with anti-cytokines (31.11%) was found to be significantly higher than in patients who were not treated with it (16.88%) (p:0.033). Furthermore, it was determined that anti-cytokine treatment significantly decreased mortality (p: 0.003) and that there was no significant relationship between CMV reactivation and mortality (p: 0.399). Conclusion: Even though CMV reactivation was high in critical COVID-19 patients who received anti-cytokine treatment, decrease in mortality were observed with early diagnosis and effective treatment. Therefore, CMV infection should be considered in patients receiving immunosuppressive treatment. Clinical Trial Registration: HisarIH-101/NCT05419206 doi: https://doi.org/10.12669/pjms.39.5.7301 How to cite this: Gozukucuk R, Kilic HH. The relationship between CMV reactivation, anti-cytokine treatment and mortality in critical COVID-19 patients. Pak J Med Sci. 2023;39(5):1286-1290. doi: https://doi.org/10.12669/pjms.39.5.7301 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

21 September 2023 in Nigerian Journal of Clinical Practice
Verified
Journal Article
Open access
RGR Gozukucuk
R Gozukucuk
HKHh Kılıc
Hh Kılıc
BUBs Uyanik
Bs Uyanik
BCB Cakiroglu
B Cakiroglu
Background: Inflammation biomarkers known as acute phase reactants (APRs) show significant variations in serum concentrations during inflammation brought on by both viral and noninfectious diseases. The erythrocyte sedimentation rate (ESR), the C-reactive protein (CRP), the lactate dehydrogenase (LDH), the ferritin, the fibrinogen, the procalcitonin, the D-dimer, and the troponin I are all significant APRs. During inflammation, the serum levels of each of these positive APRs rise. The sensitivity and specificity of hematologic parameters and indices are as high as the inflammatory biomarkers mentioned above for monitoring disease severity and treatment response. Aim: We aimed to evaluate the differences in hematological parameters and indices, and to reveal their treatment and prognostic values, especially in deceased patients with COVID-19. Materials and Methods: The hemogram parameters of 169 critical patients with COVID-19 (125 males and 44 females) who received inpatient treatment at …. between 1 March 2020 and 31 December 2021 were analyzed retrospectively. The patients were divided into two groups—deceased (77) and surviving (92)—noting demographic data such as age and gender. All analyses were performed using SPSS 25.0. Results: Analyses of the hematological parameters used during the treatment processes revealed statistically significant differences between the two patient groups. White blood cell (WBC), neutrophil, and neutrophil-to-lymphocyte ratio (NLR) values were significantly higher (P = 0.019, P = 0.000 and P = 0.000, respectively) for deceased subjects, while lymphocyte, platelet and plateletcrit (PCT) values were significantly lower (for all values, P = 0.000). Platelet volume (MPV) and platelet distribution width (PDW), as well as MPV/PLT, PDW/PLT, MPV/PCT, and PDW/PCT, levels were significantly higher in deceased subjects (P = 0.000). Particularly in our deceased cases, receiver operating characteristic analyses were performed to reveal the importance of such analyses in prognostic status evaluation in COVID-19 since the hematological parameters are quite different. Cut-off values were determined for each parameter, and sensitivity and specificity ratios were calculated. While the sensitivities of MPV/PLT, PDW/PLT, MPV/PCT, and PDW/PCT indices are over 80%, neutrophil and white blood cell sensitivities were found to be lower (74%, 68.8%, respectively). Conclusion: In addition to NLR, which is an important biomarker, the hematological indices MPV/PLT, PDW/PLT, MPV/PCT, and PDW/PCT can be used to determine the risk of death in patients with severe COVID-19.

23 April 2023 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
RGRamazan Gözüküçük
Ramazan Gözüküçük
BCBasri Cakiroglu
Basri Cakiroglu
Intravesical administration of Bacillus Calmette-Guerin (BCG) vaccine is used in the treatment of superficial bladder cancer. In clinical practice, intravesical BCG immunotherapy after transurethral tumor resection is a highly effective treatment option in preventing tumor recurrence and progression in medium and high risk superficial bladder tumors. Since patients are given live tuberculosis (TB) bacillus, serious side effects such as pneumonia, sepsis and even death can be seen. Lung involvement occurs in less than 1% of patients and most commonly presents as interstitial pneumonia or miliary TB. Miliary TB is difficult to diagnose and is usually based on high clinical suspicion, as Mycobacterium bovis is not isolated in most cases. Treatment is not completely standardized. However, in severe cases, a combination of anti-tuberculosis drugs and corticosteroids is recommended. In this report, a case of miliary tuberculosis, a very rare complication after instillation of BCG into the bladder in a patient with a diagnosis of superficial bladder cancer, was presented. A 73-year-old male patient diagnosed with bladder tumor underwent transurethral resection of bladder tumor, and then weekly intravesical injection of BCG-MEDAC for six weeks had no adverse effects. Three weeks of intravesical BCG supplementation was planned for the patient who had no signs of recurrence when checked three months later by cystoscopy. Two hours after the first dose, the patient, who applied to the emergency department with the complaint of chills and shivering, was hospitalized for further follow-up and treatment. Afterwards, repeat cultures were taken from the patient whose fever continued on the seventh day of treatment with broad-spectrum antibiotics (meropenem and teicoplanin). In addition, when abdominal and thorax computed tomography (CT) were performed, multiple miliary nodular lesions were detected in both lungs and were evaluated in favor of miliary TB. With these findings, the patient was started on miliary TB therapy [isoniazid (INH), rifampicin (RIF), ethambutol (EMB) and streptomycin (STM)] targeting Mycobacterium bovis, since it was an infection that developed after BCG injection. In the third week of the treatment, the patient's fever was under control, and he was discharged on the 25th day of his hospitalization because of significant improvement in infection markers [C-reactive protein(CRP)-procalcitonin]. At the end of two months, there was clear regression of pulmonary abnormalities on control thorax CT. In conclusion, miliary TB developing after intravesical BCG instillation is a very rare condition, the cause of which is not fully understood, the etiology of fever can be easily missed, and the diagnosis is difficult. In addition, this case is presented to draw attention to a critical disease that requires long treatment and follow-up and requires attention.

16 August 2022
Verified
Book
Closed access
PDF file
APAşkın Kadir Perçem
Aşkın Kadir Perçem
ÖÖÖzgür Önal
Özgür Önal
İÇİzzet Çeleğen
İzzet Çeleğen
ESEnes Sahin
Enes Sahin
MAMehtap Hülya Aslan
Mehtap Hülya Aslan
BMBURAK METE
BURAK METE
Buket Gülekoğlu'nun \"Yüreğimdeki Deprem\" adlı kitabı, 2019 yılında Akademisyen Kitabevi A.Ş. tarafından yayımlanmıştır. Kitap, yazarın duygusal deneyimlerini ve iç dünyasını yansıtan bir derlemedir. Yazar, kitapta ailesine, dostlarına, okurlarına ve yayınevine teşekkürlerini sunmaktadır. Buket Gülekoğlu, 1986 yılında Adana'da doğmuş ve görme engelli olarak hayatına devam etmektedir. Eğitim hayatına ara verdiği dönemde yazmaya yönelmiş ve şiirler ile kısa öyküler kaleme almıştır. Ancak görme yetisini tamamen kaybetmesiyle bu tutkusuna son vermiştir. Kitap, yazarın yaşadığı zorlu süreci ve yazma tutkusunu anlatmaktadır. Buket Gülekoğlu, görme engelliler için eğitim imkanları olduğunu öğrendikten sonra eğitimine devam etmiştir. \"Yüreğimdeki Deprem\", yazarın iç dünyasını yansıtan bir eser olup, duygusal deneyimlerini okurlarla paylaşmaktadır. Buket Gülekoğlu's book \"Yüreğimdeki Deprem\" was published in 2019 by Akademisyen Kitabevi A.Ş. The book is a collection that reflects the author's emotional experiences and inner world. In the book, the author expresses gratitude to her family, friends, readers, and the publishing house. Buket Gülekoğlu was born in Adana in 1986 and continues her life as a visually impaired person. During a break in her education, she turned to writing and wrote poems and short stories. However, she had to give up this passion completely when she lost her sight completely. The book tells the story of the author's challenging journey and her passion for writing. After learning about educational opportunities for visually impaired individuals, Buket Gülekoğlu continued her education. \"Yüreğimdeki Deprem\" is a work that reflects the author's inner world and shares her emotional experiences with readers.

11 May 2021
Verified
Book
Open access
PDF file
GAGÜLAY AÇAR
GÜLAY AÇAR
GCGulsemin Cicek
Gulsemin Cicek
EÖEmine Utlu Özen
Emine Utlu Özen
RÇRuksan Çopuroğlu
Ruksan Çopuroğlu
BGBuket Gedik
Buket Gedik
MGMeltem Gümüş
Meltem Gümüş
Karaciğer Anatomisi Gülay Açar Karaciğer Histolojisi ve Embriyolojisi Gülsemin Çiçek Emine Utlu Özen Karaciğer Hastalıklarının Patolojisi Ruksan Çopuroğlu Buket Gedik Karaciğerin Benign Kitlelerinin Patolojisi Ganime Çoban Yeliz Arman Karakaya Karaciğer Prekürsör Lezyonlarının ve Malign Tümörlerinin Patolojisi Döndü Nergiz Hülya Tosun Yıldırım Karaciğerin Hücresel Hasarı ve Fibrozis Yeliz ARMAN KARAKAYA Şirin KÜÇÜK Harun KÜÇÜK Karaciğer Fizyolojisi Ve Hücresel Fonksiyonları Güven GÜVENDİ Saime ÖZBEK ŞEBİN Safra Oluşumu Ve Fizyolojisi Metin Yalaza Yavuz Çağır İntestinal Flora Ve Karaciğer Hastalıkları -1 Murat Deveci Hafize Kızılkaya İntestinal Flora Ve Karaciğer Hastalıkları - 2 Esma Eroğlu Arzu Tarakçı Karaciğer ve İmmünite Gökçe Kundakçı Gelir Berrin Yalınbaş Kaya Hepatosellüler Karsinomun Moleküler Mekanizmaları Levent Elmas Mücahit Seçme Hepatosit Transplantasyonu Ve Kök Hücre Gülsemin Çiçek Karaciğer Ve Sirkadiyen Ritim Volkan TEKİN Karaciğer Fonksiyon Testleri Ve Güncel Gelişmeler Türkan Güney Ali Karataş Sarılıkta Patofizyoloji Ve Klinik Değerlendirme Tuba Erürker Öztürk Gebelik ve Karaciğer Özlem Koşar Can Batuhan Başpınar Karacı̇ğer ve Beslenmeye Klı̇nı̇k ve Moleküler Açıdan Yaklaşım Hatice Hamarat Özge Alkan Tali Karaciğer Hastalıklarında Girişimsel Endoskopik Yöntemler Mehmet Alpua Karaciğer Hastalıklarında Görüntüleme Mustafa Devran Aybar Karaciğerin Benign ve Malign Hastalıklarında Görüntüleme Mahmut ÇORAPLI Kamil DOĞAN Karaciğer Tümörlerinde Girişimsel Yöntemlere Cerrahi Bakış Sait Tayfun Karaciğer Hastalıkları Ve Girişimsel Radyoloji Seda Nida Karaküçük Karaciğer Tümörleri Ve Girişimsel Radyoloji Muhammet ARSLAN Halil Serdar ASLAN Karaciğer Kitlelerinde Tanı Ve Semptomatoloji Yonca Yılmaz Ürün Ferhat Bacaksız Karaciğerin Benign Kitleleri Murat Pekgöz Sevil Özer Sarı Karaciğerin Malign Kitleleri Mustafa Gürkan Haytaoğlu Karaciğerin Malign Kitlelerinde Medikal Onkoloji Ve Tedavi Rejimleri Sabri Güncan Kronik Karaciğer Hastalıklarının Etiyolojisi ve Klinik Yaklaşım Barış Soydaş Viral Hepatitler İle İlgili Genel Bilgiler Sercan Kiremitçi Hepatit B Ve D Enfeksiyonlarına Yaklaşım ve Tedavi Berk Baş Ramazan Gözüküçük Hepatit C’ye Yaklaşım ve Tedavi Zuhal Yeşilbağ Murat Pekgöz Hepatit A Virüs Enfeksiyonu Esma Kepenek Kurt Mevlüt Kıyak Hepatit E Virüs Enfeksiyonu ve Klinik Yaklaşım Esma EROĞLU Mesut GÜMÜŞSOY Sistemik Viral Enfeksiyonlar ve Karaciğer Şaban İNCECİK Vedat KILIÇ Alkolik Hepatit Rahmi ASLAN Yaren DİRİK Non-Alkolik Yağlı Karaciğer Hastalığı Tanı ve Tedavi Yaklaşımı Yakup ÜLGER Derya ARI Otoimmün Hepatit Tanı Ve Tedavisi Yavuz ÇAĞIR Primer Biliyer Kolanjit, Sekonder Biliyer Siroz, Primer Sklerozan Kolanjit, Sekonder Sklerozan Kolanjit Çağdaş Erdoğan Mehmet Köroğlu Budd-Chiari Sendromu Ve Venookluziv Hastalıkta Tanı Ve Tedavi Fatih EREN Berrin YALINBAŞ KAYA İlaç İlişkili Karaciğer Yetmezliği: Etkenler, Tanı Ve Tedavi Filiz ARAZ Akut Karaciğer Yetmezliği Murat İSPİROĞLU Mesut AYDIN Kronik Karaciğer Hastalıklarında Akut Alevlenmeler ve Yaklaşım Mustafa AKAR Çınar YILDIRIM Siroz Tedavisinde Kullanılan Başlıca İlaçlar Elif Tuğba TUNCEL Karaciğer Sirozu Ve Dekompansasyon Bilal TOKA Salih TOKMAK Karaciğer Sirozu Ve Tüm Yönleriyle Laboratuvar Değerlendirme Berat EBİK Hüseyin KAÇMAZ Portal Hipertansiyon Kübra AKAN Portal Hipertansiyona Cerrahi Yaklaşım Ufuk ARSLAN Portal Ven ve Splenik Ven Trombozuna Klinik ve Cerrahi Yaklaşım Fatih KIVRAKOĞLU Murat GÜNER M.Fevzi CELAYİR Karaciğer Hastalıklarında Anamnez Ve Fizik Muayene Mehmet KÖROĞLU Karacığer Hastalıkları Ve Nörolojık Bulgular Güven ARSLAN Hepatorenal Sendrom Murat DEVECİ Vedat GENÇER Hepatopulmoner Sendrom, Portopulmoner Hipertansiyon Çağdaş Erdoğan Mehmet Fatih Elverişli Karaciğer Hastalıkları Ve Hematopoietik Sistem, Hemostaz Funda Pepedil Tanrıkulu Filiz Araz Karaciğerin Paraziter Hastalıkları Ve Medikal Tedavi Safiye Koçulu Demir Karaciğerin Paraziter Hastalıklarında Cerrahi Tedavi Özhan Albayrak Ali Sürmelioğlu Karaciğerin Bakteriyel ve Mantar Enfeksiyonları ve Apselerine Medikal Yaklaşım Suzan Şahin Nazım Ekin Karaciğerin Bakteriyel Ve Mantar Enfeksiyonlarına Ve Apselerine Cerrahi Yaklaşım Sami Benli Dursun Burak Özdemir Karaciğer Nakli Öncesi Hasta Ve Donör Hazırlığı Şencan Acar Karaciğer Naklinde Endikasyon ve Kontrendikasyonlar Muhammed Raşid Aykota Şencan Acar Karaciğer Nakli...